Understanding Blimp1's role in lung immunity and preventing inflammation
Role of Blimp1 (Prdm1) in lung immune responses and tolerance
This work explores how a protein called Blimp1 helps keep our lungs healthy by preventing too much inflammation.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cedars-Sinai Medical Center NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11095953 on NIH RePORTER |
What this research studies
Our lungs and airways are constantly exposed to the outside world, and it's important for them to avoid ongoing inflammation. This project looks at how a specific protein, Blimp1, helps maintain a healthy immune balance in these areas. We've found that Blimp1 is crucial for certain immune cells to work correctly and prevent inflammation, especially in the gut and potentially the lungs. By studying how Blimp1 works, we hope to uncover new ways to keep our mucosal surfaces, like the lungs, free from chronic inflammation. This research uses advanced techniques and special models to observe Blimp1's activity in different tissues.
Who could benefit from this research
Good fit: This foundational research does not directly involve patient participation but aims to understand immune processes relevant to individuals with chronic lung inflammation or conditions like asthma.
Not a fit: Patients seeking immediate new treatments or direct clinical intervention would not find direct benefit from this basic science project.
Why it matters
Potential benefit: If successful, this research could lead to new ways to prevent or treat chronic inflammation in the lungs and other mucosal surfaces, potentially helping conditions like asthma.
How similar studies have performed: Previous work by this team has identified molecular pathways regulated by Blimp1 that promote immune balance in the intestines, providing a strong foundation for this continued exploration in the lungs.
Where this research is happening
Los Angeles, United States
- Cedars-Sinai Medical Center — Los Angeles, United States (Active)
Researchers
- Principal investigator: Martins, Gislaine a — Cedars-Sinai Medical Center
- Study coordinator: Martins, Gislaine a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.